Teradyne IncTER
▲ PositiveCapitalrelevance
Susquehanna raised price target to $550 from $415 and maintained Buy rating, citing upward revision in SCE backlog and higher WFE spending estimates.

Susquehanna raised its price target on Teradyne to $550 from $415 and kept a Buy rating. The firm cited channel checks indicating an upward revision in SCE backlog that now extends beyond one year, and sees wafer fab equipment spending potentially reaching $300 billion. Based on these checks, Susquehanna raised its 2026 and 2027 estimates and introduced 2028 projections for the first time, assuming a WFE level of $250 billion.
Teradyne IncSusquehanna raised price target to $550 from $415 and maintained Buy rating, citing upward revision in SCE backlog and higher WFE spending estimates.